Columbia Faculty on Two Campuses Collaborate to Make Cancer Cells Return to Normal State

Decades old research aimed at making cancer cells behave like normal cells has gained renewed attention with advances in sequencing and drug screening. Columbia’s Dr. Mark Frattini is leading a clinical trial of the drug sertraline as a means to normalize leukemia cells. Across campus, Dr. Robert Pollack marvels that the research he carried out on tumor revertants in the 1950s and 60s is back at the forefront of cancer research. The CUMC newsroom has the story.